Citroniq Chemicals Showcases Bio-Polypropylene Expansion Plans at Industry Conference

Citroniq Chemicals is a U.S.-based sustainable materials company focused on bio-based plastics, and this weekly recap highlights its latest strategic visibility push. The company announced that CEO and co-founder Kelly Knopp is delivering a keynote at the Society of Plastics Engineers Conference in Galveston, Texas, on February 24, 2026.

In the address, titled “Making Bio-Plastics the New Normal – A Sustainable Roadmap,” Knopp is expected to outline Citroniq’s plan to develop what it describes as the first world-scale bio-polypropylene facility in the U.S. Midwest. The concept centers on converting locally sourced ethanol into drop-in bio-polypropylene and generating associated carbon credits.

This approach positions Citroniq’s bio-based polypropylene as a commercially scalable alternative to conventional plastics while potentially tapping dual revenue streams from advanced materials and carbon markets. By linking its roadmap to Net Zero and decarbonization goals, the company is aligning itself with policy trends favoring low-carbon industrial solutions.

Participation as a keynote speaker at a major industry conference also serves to elevate Citroniq’s profile among plastics professionals, potential partners, and policymakers. Such exposure could support future efforts to secure project finance, offtake agreements, and incentive support for large-scale bio-plastics infrastructure.

However, the disclosed information does not include specifics on project timelines, permitting status, financing structures, or confirmed customer contracts. These execution-related factors remain critical for assessing the company’s long-term competitiveness, cost position, and ability to bring its proposed U.S. Midwest facility to fruition.

Overall, the week marked a step forward for Citroniq Chemicals in communicating its strategic vision and reinforcing its ambition in bio-polypropylene, even as key details on implementation and commercialization milestones are yet to be fully disclosed.